Theravance Biopharma Inc (TBPH) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Theravance Biopharma inc   (NASDAQ: TBPH)


Theravance Biopharma Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Theravance Biopharma Inc 's ROA in the second quarter of 2026?
Theravance Biopharma inc achieved a return on average assets (ROA) of 11.61 % in its second quarter of 2026, this is above TBPH's average return on assets of -21.51%.
Theravance Biopharma Inc assets over the 12 months ending in its second quarter of 2026 are valued at $464 million

ROA decreased relative to the period ending Mar 31 2026, due to the decline in net income.

However, within the Healthcare sector 82 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 156, from total ROA ranking in the first quarter of 2026 at 184.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 10.27 % 37.47 % 29.18 % 26.56 % 28.54 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 54 115 106 29 13
Return On Assets (TTM) 11.61 % 25.31 % 25.19 % 7.48 % 3.52 %
TBPH's Total Ranking # 156 # 184 # 812 # 1465 # 3539
Total Assets (TTM) in million 470 472 497 415 426
Seq. Total Assets Change -0.54 % -4.91 % 19.55 % -2.48 % 24 %
Seq. Net Income Change - - 1588.08 % -93.41 % -

TBPH's 5 Years Annual ROA >> Back to TBPH Management Effectiveness >> Compare TBPH ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 36
Sector # 83
Overall # 506

Return On Assets Statistics
High Average Low
183.44 %
-21.51 %
-80.61 %
(Sep 30 2022)   (Dec 31 2014)





Financial Statements
Theravance Biopharma Inc 's Assets $ 470 million TBPH's Balance sheet
Theravance Biopharma Inc 's Income $ -6 million Quarterly TBPH's Income Statement
TBPH's Income by Division See TBPH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 52.14 % -27.7 % -20.55 % 68.61 % -21.16 %
Total Assets in million 497 326 452 568 337
Y / Y Net Income Change - - - - -
Net Income in million 106 -56 -55 872 -199
Annual Return On Assets 21.32 % -17.28 % -12.22 % 153.45 % -59.17 %

TBPH's 5 Years Annual ROA >> Back to TBPH Management Effectiveness >> Compare TBPH ROA to its Competitors



Comment on TBPH's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 21.32 % compared to prior year, due to annual net income growth of % to $105.90 million, while value of Theravance Biopharma Inc 's overall assets grew just by 52.14 % to $496.70 million, compared to $496.70 a year before.


More Return On Assets Ratios
TBPH's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TBPH's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TBPH's Competitors
Subscribers only: Roa for Theravance Biopharma Inc 's Suppliers
Subscribers only: Return On Assets for TBPH's Customers

You may also want to know
TBPH's Roi TBPH's Inventory Turnover Ratio TBPH's Growth Rates TBPH's Dividend Comparisons
TBPH's Profitability Ratios TBPH's Asset Turnover Ratio TBPH's Dividend Growth
TBPH's Roe TBPH's Valuation Ratios TBPH's Financial Strength Ratios TBPH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %

Date modified: 2026-09-05T15:34:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.